English

APPLIED GENETIC TECHNOLOGIES CORP

EDGAR

AGTC Quarterly report (10-Q) · filed 2022-11-21

156 filing records in this dataset, filed from 2014-01-10 to 2022-11-21. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-16 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -16037000 USD Source

Free cash flow

-16.2 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -16037000 USD Source
Capital Expenditure: 183000 USD Source

Cash and cash equivalents: 34.2 million USD 2022-09-30 Source
Exact value

34200000 USD
Long-term debt including current maturities: 6.81 million USD 2022-09-30 Source
Exact value

6812000 USD
Shares outstanding: 67.6 million shares 2022-09-30 Source
Exact value

67632000 shares

Reported share-count change

57.80% · 24.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

42859000 shares · 2021-09-30· Source
67632000 shares · 2022-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

325 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Revenue: 0 USD · 2021-10-01 – 2021-12-31 Source
Revenue: 0 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 325000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 0 USD · 2022-07-01 – 2022-09-30 Source

Net income

-70.2 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Net income: -19144000 USD · 2021-10-01 – 2021-12-31 Source
Net income: -14294000 USD · 2022-01-01 – 2022-03-31 Source
Net income: -18386000 USD · 2022-04-01 – 2022-06-30 Source
Net income: -18410000 USD · 2022-07-01 – 2022-09-30 Source

Operating cash flow

-65.8 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -33493000 USD · 2021-07-01 – 2021-12-31 Source
Operating cash flow: -15936000 USD · 2021-07-01 – 2021-09-30 Source
Operating cash flow: -47490000 USD · 2021-07-01 – 2022-03-31 Source
Operating cash flow: -33493000 USD · 2021-07-01 – 2021-12-31 Source
Operating cash flow: -65748000 USD · 2021-07-01 – 2022-06-30 Source
Operating cash flow: -47490000 USD · 2021-07-01 – 2022-03-31 Source
Operating cash flow: -16037000 USD · 2022-07-01 – 2022-09-30 Source

Capital expenditure

1.31 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Capital expenditure: 821000 USD · 2021-07-01 – 2021-12-31 Source
Capital expenditure: 545000 USD · 2021-07-01 – 2021-09-30 Source
Capital expenditure: 900000 USD · 2021-07-01 – 2022-03-31 Source
Capital expenditure: 821000 USD · 2021-07-01 – 2021-12-31 Source
Capital expenditure: 1670000 USD · 2021-07-01 – 2022-06-30 Source
Capital expenditure: 900000 USD · 2021-07-01 – 2022-03-31 Source
Capital expenditure: 183000 USD · 2022-07-01 – 2022-09-30 Source

Free cash flow

-67.2 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -33493000 USD · 2021-07-01 – 2021-12-31 Source
Operating cash flow: -15936000 USD · 2021-07-01 – 2021-09-30 Source
Operating cash flow: -47490000 USD · 2021-07-01 – 2022-03-31 Source
Operating cash flow: -33493000 USD · 2021-07-01 – 2021-12-31 Source
Operating cash flow: -65748000 USD · 2021-07-01 – 2022-06-30 Source
Operating cash flow: -47490000 USD · 2021-07-01 – 2022-03-31 Source
Operating cash flow: -16037000 USD · 2022-07-01 – 2022-09-30 Source
Capital expenditure: 821000 USD · 2021-07-01 – 2021-12-31 Source
Capital expenditure: 545000 USD · 2021-07-01 – 2021-09-30 Source
Capital expenditure: 900000 USD · 2021-07-01 – 2022-03-31 Source
Capital expenditure: 821000 USD · 2021-07-01 – 2021-12-31 Source
Capital expenditure: 1670000 USD · 2021-07-01 – 2022-06-30 Source
Capital expenditure: 900000 USD · 2021-07-01 – 2022-03-31 Source
Capital expenditure: 183000 USD · 2022-07-01 – 2022-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-11-21.

Financial data available through: 2022-06-30.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-06-30
Operating income: 11 of 11 periods available· newest 2022-06-30
Net income: 11 of 11 periods available· newest 2022-06-30
Operating cash flow: 11 of 11 periods available· newest 2022-06-30
Capital expenditure: 11 of 11 periods available· newest 2022-06-30
Total assets: 11 of 11 periods available· newest 2022-06-30
Total liabilities: 11 of 11 periods available· newest 2022-06-30
Current assets: 11 of 11 periods available· newest 2022-06-30
Current liabilities: 11 of 11 periods available· newest 2022-06-30
Cash and cash equivalents: 11 of 11 periods available· newest 2022-06-30
Long-term debt including current maturities: 3 of 11 periods available· newest 2022-06-30
Shares outstanding: 11 of 11 periods available· newest 2022-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-35%

Prior period

USD 500,000

2020-07-01 – 2021-06-30
Current period

USD 325,000

2021-07-01 – 2022-06-30

Exact inputs and evidence

325000 − 500000 = -175000 USD

500000 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
325000 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Year-over-year change in Revenue: -175000 USD Concept: fundies:Revenue Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 325000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1311734 Filing: 000119312522252231 Input fundies:Revenue: 500000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1312213 Filing: 000119312522252231
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 11.11 million

Prior period

−USD 57.83 million

2020-07-01 – 2021-06-30
Current period

−USD 68.94 million

2021-07-01 – 2022-06-30

Exact inputs and evidence

-68943000 − -57829000 = -11114000 USD

-57829000 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
-68943000 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Year-over-year change in Net income: -11114000 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -68943000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1423574 Filing: 000119312522252231 Input fundies:NetIncome: -57829000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1424024 Filing: 000119312522252231
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 14.58 million

Prior period

−USD 51.17 million

2020-07-01 – 2021-06-30
Current period

−USD 65.75 million

2021-07-01 – 2022-06-30

Exact inputs and evidence

-65748000 − -51173000 = -14575000 USD

-51173000 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
-65748000 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Year-over-year change in Operating cash flow: -14575000 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -65748000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445499 Filing: 000119312522252231 Input fundies:OperatingCashFlow: -51173000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445983 Filing: 000119312522252231
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+14.6%

Prior period

USD 1.46 million

2020-07-01 – 2021-06-30
Current period

USD 1.67 million

2021-07-01 – 2022-06-30

Exact inputs and evidence

1670000 − 1457000 = 213000 USD

1457000 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
1670000 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Year-over-year change in Capital expenditure: 213000 USD Concept: fundies:CapitalExpenditure Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1670000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449358 Filing: 000119312522252231 Input fundies:CapitalExpenditure: 1457000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449832 Filing: 000119312522252231
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-07-01 – 2022-06-30

Revenue USD 325,000 100% of revenue
Operating costs Derived USD 66.5 million 20,462% of revenue
Operating income −USD 66.18 million −20,362% of revenue
Tax, interest and other Derived USD 2.77 million 852% of revenue
Net income −USD 68.94 million −21,213% of revenue

Cash

Operating cash flow −USD 65.75 million −20,230% of revenue
Capital expenditure USD 1.67 million 514% of revenue
Free cash flow Derived −USD 67.42 million −20,744% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 482% of revenue.
2014 Operating loss: operating costs were 1,212% of revenue.
2015 Operating loss: operating costs were 1,142% of revenue.
2016 Operating loss: operating costs were 104% of revenue.
2017 95%
2018 Operating loss: operating costs were 193% of revenue.
2019 Operating loss: operating costs were 110% of revenue.
2020 Operating loss: operating costs were 2,014% of revenue.
2021 Operating loss: operating costs were 11,790% of revenue.
2022 Operating loss: operating costs were 20,462% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2012-07-01 – 2013-06-30	942000	4536000 Derived	-3594000	1396000 Derived	-4990000	-3129000 Derived	Source 2012-07-01 – 2013-06-30: 942000 USD Inspect Revenue Open source 2012-07-01 – 2013-06-30: -3594000 USD Inspect Operating Income Open source 2012-07-01 – 2013-06-30: -4990000 USD Inspect Net Income Open source 2012-07-01 – 2013-06-30: -2777000 USD Inspect Operating Cash Flow Open source 2012-07-01 – 2013-06-30: 352000 USD Inspect Capital Expenditure Open source
2014 2013-07-01 – 2014-06-30	1129000	13685000 Derived	-12556000	3352000 Derived	-15908000	-12086000 Derived	Source 2013-07-01 – 2014-06-30: 1129000 USD Inspect Revenue Open source 2013-07-01 – 2014-06-30: -12556000 USD Inspect Operating Income Open source 2013-07-01 – 2014-06-30: -15908000 USD Inspect Net Income Open source 2013-07-01 – 2014-06-30: -11928000 USD Inspect Operating Cash Flow Open source 2013-07-01 – 2014-06-30: 158000 USD Inspect Capital Expenditure Open source
2015 2014-07-01 – 2015-06-30	2354000	26886000 Derived	-24532000	-214000 Derived	-24318000	-19710000 Derived	Source 2014-07-01 – 2015-06-30: 2354000 USD Inspect Revenue Open source 2014-07-01 – 2015-06-30: -24532000 USD Inspect Operating Income Open source 2014-07-01 – 2015-06-30: -24318000 USD Inspect Net Income Open source 2014-07-01 – 2015-06-30: -19485000 USD Inspect Operating Cash Flow Open source 2014-07-01 – 2015-06-30: 225000 USD Inspect Capital Expenditure Open source
2016 2015-07-01 – 2016-06-30	47361000	49450000 Derived	-2089000	-708000 Derived	-1381000	68520000 Derived	Source 2015-07-01 – 2016-06-30: 47361000 USD Inspect Revenue Open source 2015-07-01 – 2016-06-30: -2089000 USD Inspect Operating Income Open source 2015-07-01 – 2016-06-30: -1381000 USD Inspect Net Income Open source 2015-07-01 – 2016-06-30: 70991000 USD Inspect Operating Cash Flow Open source 2015-07-01 – 2016-06-30: 2471000 USD Inspect Capital Expenditure Open source
2017 2016-07-01 – 2017-06-30	39473000	37571000 Derived	1902000	1495000 Derived	407000	-31740000 Derived	Source 2016-07-01 – 2017-06-30: 39473000 USD Inspect Revenue Open source 2016-07-01 – 2017-06-30: 1902000 USD Inspect Operating Income Open source 2016-07-01 – 2017-06-30: 407000 USD Inspect Net Income Open source 2016-07-01 – 2017-06-30: -31001000 USD Inspect Operating Cash Flow Open source 2016-07-01 – 2017-06-30: 739000 USD Inspect Capital Expenditure Open source
2018 2017-07-01 – 2018-06-30	24186000	46570000 Derived	-22384000	-1084000 Derived	-21300000	-33182000 Derived	Source 2017-07-01 – 2018-06-30: 24186000 USD Inspect Revenue Open source 2017-07-01 – 2018-06-30: -22384000 USD Inspect Operating Income Open source 2017-07-01 – 2018-06-30: -21300000 USD Inspect Net Income Open source 2017-07-01 – 2018-06-30: -32520000 USD Inspect Operating Cash Flow Open source 2017-07-01 – 2018-06-30: 662000 USD Inspect Capital Expenditure Open source
2019 2018-07-01 – 2019-06-30	41692000	46042000 Derived	-4350000	-2344000 Derived	-2006000	-23620000 Derived	Source 2018-07-01 – 2019-06-30: 41692000 USD Inspect Revenue Open source 2018-07-01 – 2019-06-30: -4350000 USD Inspect Operating Income Open source 2018-07-01 – 2019-06-30: -2006000 USD Inspect Net Income Open source 2018-07-01 – 2019-06-30: -23457000 USD Inspect Operating Cash Flow Open source 2018-07-01 – 2019-06-30: 163000 USD Inspect Capital Expenditure Open source
2020 2019-07-01 – 2020-06-30	2453000	49395000 Derived	-46942000	-1050000 Derived	-45892000	-42563000 Derived	Source 2019-07-01 – 2020-06-30: 2453000 USD Inspect Revenue Open source 2019-07-01 – 2020-06-30: -46942000 USD Inspect Operating Income Open source 2019-07-01 – 2020-06-30: -45892000 USD Inspect Net Income Open source 2019-07-01 – 2020-06-30: -41620000 USD Inspect Operating Cash Flow Open source 2019-07-01 – 2020-06-30: 943000 USD Inspect Capital Expenditure Open source
2021 2020-07-01 – 2021-06-30	500000	58951000 Derived	-58451000	-622000 Derived	-57829000	-52630000 Derived	Source 2020-07-01 – 2021-06-30: 500000 USD Inspect Revenue Open source 2020-07-01 – 2021-06-30: -58451000 USD Inspect Operating Income Open source 2020-07-01 – 2021-06-30: -57829000 USD Inspect Net Income Open source 2020-07-01 – 2021-06-30: -51173000 USD Inspect Operating Cash Flow Open source 2020-07-01 – 2021-06-30: 1457000 USD Inspect Capital Expenditure Open source
2022 2021-07-01 – 2022-06-30	325000	66500000 Derived	-66175000	2768000 Derived	-68943000	-67418000 Derived	Source 2021-07-01 – 2022-06-30: 325000 USD Inspect Revenue Open source 2021-07-01 – 2022-06-30: -66175000 USD Inspect Operating Income Open source 2021-07-01 – 2022-06-30: -68943000 USD Inspect Net Income Open source 2021-07-01 – 2022-06-30: -65748000 USD Inspect Operating Cash Flow Open source 2021-07-01 – 2022-06-30: 1670000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 325K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Revenue	942000	Revenue: 942000 Open source
20142014-06-30	Revenue	1129000	Revenue: 1129000 Open source
20152015-06-30	Revenue	2354000	Revenue: 2354000 Open source
20162016-06-30	Revenue	47361000	Revenue: 47361000 Open source
20172017-06-30	Revenue	39473000	Revenue: 39473000 Open source
20182018-06-30	Revenue	24186000	Revenue: 24186000 Open source
20192019-06-30	Revenue	41692000	Revenue: 41692000 Open source
20202020-06-30	Revenue	2453000	Revenue: 2453000 Open source
20212021-06-30	Revenue	500000	Revenue: 500000 Open source
20222022-06-30	Revenue	325000	Revenue: 325000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-35% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Year over year	-12.9%	Revenue: 942000 Open source Revenue: 1082000 Open source
20142014-06-30	Year over year	19.9%	Revenue: 1129000 Open source Revenue: 942000 Open source
20152015-06-30	Year over year	108.5%	Revenue: 2354000 Open source Revenue: 1129000 Open source
20162016-06-30	Year over year	1,911.9%	Revenue: 47361000 Open source Revenue: 2354000 Open source
20172017-06-30	Year over year	-16.7%	Revenue: 39473000 Open source Revenue: 47361000 Open source
20182018-06-30	Year over year	-38.7%	Revenue: 24186000 Open source Revenue: 39473000 Open source
20192019-06-30	Year over year	72.4%	Revenue: 41692000 Open source Revenue: 24186000 Open source
20202020-06-30	Year over year	-94.1%	Revenue: 2453000 Open source Revenue: 41692000 Open source
20212021-06-30	Year over year	-79.6%	Revenue: 500000 Open source Revenue: 2453000 Open source
20222022-06-30	Year over year	-35%	Revenue: 325000 Open source Revenue: 500000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -20,361.5% 2022

Net margin -21,213.2% 2022

Free cash flow margin -20,744% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Operating margin	-381.5%	Operating Income: -3594000 Open source Revenue: 942000 Open source
20142014-06-30	Operating margin	-1,112.1%	Operating Income: -12556000 Open source Revenue: 1129000 Open source
20152015-06-30	Operating margin	-1,042.1%	Operating Income: -24532000 Open source Revenue: 2354000 Open source
20162016-06-30	Operating margin	-4.4%	Operating Income: -2089000 Open source Revenue: 47361000 Open source
20172017-06-30	Operating margin	4.8%	Operating Income: 1902000 Open source Revenue: 39473000 Open source
20182018-06-30	Operating margin	-92.5%	Operating Income: -22384000 Open source Revenue: 24186000 Open source
20192019-06-30	Operating margin	-10.4%	Operating Income: -4350000 Open source Revenue: 41692000 Open source
20202020-06-30	Operating margin	-1,913.7%	Operating Income: -46942000 Open source Revenue: 2453000 Open source
20212021-06-30	Operating margin	-11,690.2%	Operating Income: -58451000 Open source Revenue: 500000 Open source
20222022-06-30	Operating margin	-20,361.5%	Operating Income: -66175000 Open source Revenue: 325000 Open source
20132013-06-30	Net margin	-529.7%	Net Income: -4990000 Open source Revenue: 942000 Open source
20142014-06-30	Net margin	-1,409%	Net Income: -15908000 Open source Revenue: 1129000 Open source
20152015-06-30	Net margin	-1,033.1%	Net Income: -24318000 Open source Revenue: 2354000 Open source
20162016-06-30	Net margin	-2.9%	Net Income: -1381000 Open source Revenue: 47361000 Open source
20172017-06-30	Net margin	1%	Net Income: 407000 Open source Revenue: 39473000 Open source
20182018-06-30	Net margin	-88.1%	Net Income: -21300000 Open source Revenue: 24186000 Open source
20192019-06-30	Net margin	-4.8%	Net Income: -2006000 Open source Revenue: 41692000 Open source
20202020-06-30	Net margin	-1,870.9%	Net Income: -45892000 Open source Revenue: 2453000 Open source
20212021-06-30	Net margin	-11,565.8%	Net Income: -57829000 Open source Revenue: 500000 Open source
20222022-06-30	Net margin	-21,213.2%	Net Income: -68943000 Open source Revenue: 325000 Open source
20132013-06-30	Free cash flow margin	-332.2%	Revenue: 942000 Open source Operating Cash Flow: -2777000 Open source Capital Expenditure: 352000 Open source
20142014-06-30	Free cash flow margin	-1,070.5%	Revenue: 1129000 Open source Operating Cash Flow: -11928000 Open source Capital Expenditure: 158000 Open source
20152015-06-30	Free cash flow margin	-837.3%	Revenue: 2354000 Open source Operating Cash Flow: -19485000 Open source Capital Expenditure: 225000 Open source
20162016-06-30	Free cash flow margin	144.7%	Revenue: 47361000 Open source Operating Cash Flow: 70991000 Open source Capital Expenditure: 2471000 Open source
20172017-06-30	Free cash flow margin	-80.4%	Revenue: 39473000 Open source Operating Cash Flow: -31001000 Open source Capital Expenditure: 739000 Open source
20182018-06-30	Free cash flow margin	-137.2%	Revenue: 24186000 Open source Operating Cash Flow: -32520000 Open source Capital Expenditure: 662000 Open source
20192019-06-30	Free cash flow margin	-56.7%	Revenue: 41692000 Open source Operating Cash Flow: -23457000 Open source Capital Expenditure: 163000 Open source
20202020-06-30	Free cash flow margin	-1,735.1%	Revenue: 2453000 Open source Operating Cash Flow: -41620000 Open source Capital Expenditure: 943000 Open source
20212021-06-30	Free cash flow margin	-10,526%	Revenue: 500000 Open source Operating Cash Flow: -51173000 Open source Capital Expenditure: 1457000 Open source
20222022-06-30	Free cash flow margin	-20,744%	Revenue: 325000 Open source Operating Cash Flow: -65748000 Open source Capital Expenditure: 1670000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -65.7M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Operating cash flow	-2777000	Operating Cash Flow: -2777000 Open source
20142014-06-30	Operating cash flow	-11928000	Operating Cash Flow: -11928000 Open source
20152015-06-30	Operating cash flow	-19485000	Operating Cash Flow: -19485000 Open source
20162016-06-30	Operating cash flow	70991000	Operating Cash Flow: 70991000 Open source
20172017-06-30	Operating cash flow	-31001000	Operating Cash Flow: -31001000 Open source
20182018-06-30	Operating cash flow	-32520000	Operating Cash Flow: -32520000 Open source
20192019-06-30	Operating cash flow	-23457000	Operating Cash Flow: -23457000 Open source
20202020-06-30	Operating cash flow	-41620000	Operating Cash Flow: -41620000 Open source
20212021-06-30	Operating cash flow	-51173000	Operating Cash Flow: -51173000 Open source
20222022-06-30	Operating cash flow	-65748000	Operating Cash Flow: -65748000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -67.4M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Free cash flow	-3129000	Operating Cash Flow: -2777000 Open source Capital Expenditure: 352000 Open source
20142014-06-30	Free cash flow	-12086000	Operating Cash Flow: -11928000 Open source Capital Expenditure: 158000 Open source
20152015-06-30	Free cash flow	-19710000	Operating Cash Flow: -19485000 Open source Capital Expenditure: 225000 Open source
20162016-06-30	Free cash flow	68520000	Operating Cash Flow: 70991000 Open source Capital Expenditure: 2471000 Open source
20172017-06-30	Free cash flow	-31740000	Operating Cash Flow: -31001000 Open source Capital Expenditure: 739000 Open source
20182018-06-30	Free cash flow	-33182000	Operating Cash Flow: -32520000 Open source Capital Expenditure: 662000 Open source
20192019-06-30	Free cash flow	-23620000	Operating Cash Flow: -23457000 Open source Capital Expenditure: 163000 Open source
20202020-06-30	Free cash flow	-42563000	Operating Cash Flow: -41620000 Open source Capital Expenditure: 943000 Open source
20212021-06-30	Free cash flow	-52630000	Operating Cash Flow: -51173000 Open source Capital Expenditure: 1457000 Open source
20222022-06-30	Free cash flow	-67418000	Operating Cash Flow: -65748000 Open source Capital Expenditure: 1670000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.8% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Liabilities / assets	14%	Total Liabilities: 3570000 Open source Total Assets: 25490000 Open source
20142014-06-30	Liabilities / assets	3.3%	Total Liabilities: 2534000 Open source Total Assets: 77407000 Open source
20152015-06-30	Liabilities / assets	5.1%	Total Liabilities: 4642000 Open source Total Assets: 90174000 Open source
20162016-06-30	Liabilities / assets	39.6%	Total Liabilities: 71509000 Open source Total Assets: 180797000 Open source
20172017-06-30	Liabilities / assets	22%	Total Liabilities: 32594000 Open source Total Assets: 147923000 Open source
20182018-06-30	Liabilities / assets	16.3%	Total Liabilities: 19350000 Open source Total Assets: 118532000 Open source
20192019-06-30	Liabilities / assets	14.6%	Total Liabilities: 13507000 Open source Total Assets: 92216000 Open source
20202020-06-30	Liabilities / assets	29.2%	Total Liabilities: 29303000 Open source Total Assets: 100319000 Open source
20212021-06-30	Liabilities / assets	32.4%	Total Liabilities: 41158000 Open source Total Assets: 126966000 Open source
20222022-06-30	Liabilities / assets	55.8%	Total Liabilities: 37207000 Open source Total Assets: 66684000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.97× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Current assets / current liabilities	6.8×	Current Assets: 23511000 Open source Current Liabilities: 3460000 Open source
20142014-06-30	Current assets / current liabilities	29.77×	Current Assets: 75436000 Open source Current Liabilities: 2534000 Open source
20152015-06-30	Current assets / current liabilities	13.82×	Current Assets: 64132000 Open source Current Liabilities: 4642000 Open source
20162016-06-30	Current assets / current liabilities	1.87×	Current Assets: 102575000 Open source Current Liabilities: 54743000 Open source
20172017-06-30	Current assets / current liabilities	4.63×	Current Assets: 130235000 Open source Current Liabilities: 28156000 Open source
20182018-06-30	Current assets / current liabilities	7.58×	Current Assets: 109124000 Open source Current Liabilities: 14395000 Open source
20192019-06-30	Current assets / current liabilities	9.01×	Current Assets: 84284000 Open source Current Liabilities: 9355000 Open source
20202020-06-30	Current assets / current liabilities	6.4×	Current Assets: 82964000 Open source Current Liabilities: 12963000 Open source
20212021-06-30	Current assets / current liabilities	5.56×	Current Assets: 109707000 Open source Current Liabilities: 19714000 Open source
20222022-06-30	Current assets / current liabilities	1.97×	Current Assets: 49561000 Open source Current Liabilities: 25207000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2012-07-01 – 2013-06-30	−USD 4.99 million Exact value Exact value: -4990000 USD 2012-07-01 – 2013-06-30: -4990000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2013-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -4990000 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:NetIncome: -4990000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459015007858/agtc-20150630.xml#130968 Filing: 000156459015007858 The citation records this snapshot. The page link may show a newer release later.	−USD 2.78 million Exact value Exact value: -2777000 USD 2012-07-01 – 2013-06-30: -2777000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2013-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -2777000 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2777000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459015007858/agtc-20150630.xml#148397 Filing: 000156459015007858 The citation records this snapshot. The page link may show a newer release later.	USD 352,000 Exact value Exact value: 352000 USD 2012-07-01 – 2013-06-30: 352000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2013-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 352000 USD Concept: fundies:CapitalExpenditure Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 352000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459015007858/agtc-20150630.xml#149066 Filing: 000156459015007858 The citation records this snapshot. The page link may show a newer release later.	−USD 3.13 million Calculation and evidence -2777000 − 352000 USD Exact free cash flow: -3129000 USD 2012-07-01 – 2013-06-30: -2777000 USD · Inspect Operating Cash Flow · Source 2012-07-01 – 2013-06-30: 352000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2013-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -3129000 USD Concept: free-cash-flow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2777000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459015007858/agtc-20150630.xml#148397 Filing: 000156459015007858 Input fundies:CapitalExpenditure: 352000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459015007858/agtc-20150630.xml#149066 Filing: 000156459015007858 The citation records this snapshot. The page link may show a newer release later.
2014 2013-07-01 – 2014-06-30	−USD 15.91 million Exact value Exact value: -15908000 USD 2013-07-01 – 2014-06-30: -15908000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2014-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -15908000 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15908000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312517280588/agtc-20160630.xml#110121 Filing: 000119312517280588 The citation records this snapshot. The page link may show a newer release later.	−USD 11.93 million Exact value Exact value: -11928000 USD 2013-07-01 – 2014-06-30: -11928000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2014-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -11928000 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11928000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312517280588/agtc-20160630.xml#102893 Filing: 000119312517280588 The citation records this snapshot. The page link may show a newer release later.	USD 158,000 Exact value Exact value: 158000 USD 2013-07-01 – 2014-06-30: 158000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2014-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 158000 USD Concept: fundies:CapitalExpenditure Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 158000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312517280588/agtc-20160630.xml#108843 Filing: 000119312517280588 The citation records this snapshot. The page link may show a newer release later.	−USD 12.09 million Calculation and evidence -11928000 − 158000 USD Exact free cash flow: -12086000 USD 2013-07-01 – 2014-06-30: -11928000 USD · Inspect Operating Cash Flow · Source 2013-07-01 – 2014-06-30: 158000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2014-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -12086000 USD Concept: free-cash-flow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11928000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312517280588/agtc-20160630.xml#102893 Filing: 000119312517280588 Input fundies:CapitalExpenditure: 158000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312517280588/agtc-20160630.xml#108843 Filing: 000119312517280588 The citation records this snapshot. The page link may show a newer release later.
2015 2014-07-01 – 2015-06-30	−USD 24.32 million Exact value Exact value: -24318000 USD 2014-07-01 – 2015-06-30: -24318000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2015-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -24318000 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:NetIncome: -24318000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459017018636/agtc-20170630.xml#144109 Filing: 000156459017018636 The citation records this snapshot. The page link may show a newer release later.	−USD 19.49 million Exact value Exact value: -19485000 USD 2014-07-01 – 2015-06-30: -19485000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2015-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -19485000 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19485000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459017018636/agtc-20170630.xml#164477 Filing: 000156459017018636 The citation records this snapshot. The page link may show a newer release later.	USD 225,000 Exact value Exact value: 225000 USD 2014-07-01 – 2015-06-30: 225000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2015-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 225000 USD Concept: fundies:CapitalExpenditure Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 225000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459017018636/agtc-20170630.xml#165148 Filing: 000156459017018636 The citation records this snapshot. The page link may show a newer release later.	−USD 19.71 million Calculation and evidence -19485000 − 225000 USD Exact free cash flow: -19710000 USD 2014-07-01 – 2015-06-30: -19485000 USD · Inspect Operating Cash Flow · Source 2014-07-01 – 2015-06-30: 225000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2015-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -19710000 USD Concept: free-cash-flow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19485000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459017018636/agtc-20170630.xml#164477 Filing: 000156459017018636 Input fundies:CapitalExpenditure: 225000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459017018636/agtc-20170630.xml#165148 Filing: 000156459017018636 The citation records this snapshot. The page link may show a newer release later.
2016 2015-07-01 – 2016-06-30	−USD 1.38 million Exact value Exact value: -1381000 USD 2015-07-01 – 2016-06-30: -1381000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2016-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -1381000 USD Concept: fundies:NetIncome Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1381000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#147727 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	USD 70.99 million Exact value Exact value: 70991000 USD 2015-07-01 – 2016-06-30: 70991000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2016-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: 70991000 USD Concept: fundies:OperatingCashFlow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 70991000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169544 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	USD 2.47 million Exact value Exact value: 2471000 USD 2015-07-01 – 2016-06-30: 2471000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2016-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 2471000 USD Concept: fundies:CapitalExpenditure Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2471000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#170173 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	USD 68.52 million Calculation and evidence 70991000 − 2471000 USD Exact free cash flow: 68520000 USD 2015-07-01 – 2016-06-30: 70991000 USD · Inspect Operating Cash Flow · Source 2015-07-01 – 2016-06-30: 2471000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2016-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: 68520000 USD Concept: free-cash-flow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 70991000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169544 Filing: 000156459018022913 Input fundies:CapitalExpenditure: 2471000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#170173 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.
2017 2016-07-01 – 2017-06-30	USD 407,000 Exact value Exact value: 407000 USD 2016-07-01 – 2017-06-30: 407000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2017-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: 407000 USD Concept: fundies:NetIncome Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:NetIncome: 407000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#147576 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	−USD 31 million Exact value Exact value: -31001000 USD 2016-07-01 – 2017-06-30: -31001000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2017-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -31001000 USD Concept: fundies:OperatingCashFlow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31001000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169332 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	USD 739,000 Exact value Exact value: 739000 USD 2016-07-01 – 2017-06-30: 739000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2017-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 739000 USD Concept: fundies:CapitalExpenditure Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 739000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169964 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.	−USD 31.74 million Calculation and evidence -31001000 − 739000 USD Exact free cash flow: -31740000 USD 2016-07-01 – 2017-06-30: -31001000 USD · Inspect Operating Cash Flow · Source 2016-07-01 – 2017-06-30: 739000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2017-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -31740000 USD Concept: free-cash-flow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31001000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169332 Filing: 000156459018022913 Input fundies:CapitalExpenditure: 739000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/agtc-20180630.xml#169964 Filing: 000156459018022913 The citation records this snapshot. The page link may show a newer release later.
2018 2017-07-01 – 2018-06-30	−USD 21.3 million Exact value Exact value: -21300000 USD 2017-07-01 – 2018-06-30: -21300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2018-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -21300000 USD Concept: fundies:NetIncome Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21300000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/agtc-20190630.xml#124832 Filing: 000119312519255968 The citation records this snapshot. The page link may show a newer release later.	−USD 32.52 million Exact value Exact value: -32520000 USD 2017-07-01 – 2018-06-30: -32520000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2018-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -32520000 USD Concept: fundies:OperatingCashFlow Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32520000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/agtc-20190630.xml#134415 Filing: 000119312519255968 The citation records this snapshot. The page link may show a newer release later.	USD 662,000 Exact value Exact value: 662000 USD 2017-07-01 – 2018-06-30: 662000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2018-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 662000 USD Concept: fundies:CapitalExpenditure Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 662000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/agtc-20190630.xml#134822 Filing: 000119312519255968 The citation records this snapshot. The page link may show a newer release later.	−USD 33.18 million Calculation and evidence -32520000 − 662000 USD Exact free cash flow: -33182000 USD 2017-07-01 – 2018-06-30: -32520000 USD · Inspect Operating Cash Flow · Source 2017-07-01 – 2018-06-30: 662000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2018-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -33182000 USD Concept: free-cash-flow Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32520000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/agtc-20190630.xml#134415 Filing: 000119312519255968 Input fundies:CapitalExpenditure: 662000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/agtc-20190630.xml#134822 Filing: 000119312519255968 The citation records this snapshot. The page link may show a newer release later.
2019 2018-07-01 – 2019-06-30	−USD 2.01 million Exact value Exact value: -2006000 USD 2018-07-01 – 2019-06-30: -2006000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2019-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -2006000 USD Concept: fundies:NetIncome Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2006000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/agtc-20200630.xml#113876 Filing: 000119312520249103 The citation records this snapshot. The page link may show a newer release later.	−USD 23.46 million Exact value Exact value: -23457000 USD 2018-07-01 – 2019-06-30: -23457000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2019-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -23457000 USD Concept: fundies:OperatingCashFlow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23457000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/agtc-20200630.xml#135700 Filing: 000119312520249103 The citation records this snapshot. The page link may show a newer release later.	USD 163,000 Exact value Exact value: 163000 USD 2018-07-01 – 2019-06-30: 163000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2019-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 163000 USD Concept: fundies:CapitalExpenditure Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 163000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/agtc-20200630.xml#120048 Filing: 000119312520249103 The citation records this snapshot. The page link may show a newer release later.	−USD 23.62 million Calculation and evidence -23457000 − 163000 USD Exact free cash flow: -23620000 USD 2018-07-01 – 2019-06-30: -23457000 USD · Inspect Operating Cash Flow · Source 2018-07-01 – 2019-06-30: 163000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2019-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -23620000 USD Concept: free-cash-flow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23457000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/agtc-20200630.xml#135700 Filing: 000119312520249103 Input fundies:CapitalExpenditure: 163000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/agtc-20200630.xml#120048 Filing: 000119312520249103 The citation records this snapshot. The page link may show a newer release later.
2020 2019-07-01 – 2020-06-30	−USD 45.89 million Exact value Exact value: -45892000 USD 2019-07-01 – 2020-06-30: -45892000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2020-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -45892000 USD Concept: fundies:NetIncome Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:NetIncome: -45892000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/agtc-20210630.xml#104250 Filing: 000119312521280686 The citation records this snapshot. The page link may show a newer release later.	−USD 41.62 million Exact value Exact value: -41620000 USD 2019-07-01 – 2020-06-30: -41620000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2020-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -41620000 USD Concept: fundies:OperatingCashFlow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41620000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/agtc-20210630.xml#100902 Filing: 000119312521280686 The citation records this snapshot. The page link may show a newer release later.	USD 943,000 Exact value Exact value: 943000 USD 2019-07-01 – 2020-06-30: 943000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2020-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 943000 USD Concept: fundies:CapitalExpenditure Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 943000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/agtc-20210630.xml#102264 Filing: 000119312521280686 The citation records this snapshot. The page link may show a newer release later.	−USD 42.56 million Calculation and evidence -41620000 − 943000 USD Exact free cash flow: -42563000 USD 2019-07-01 – 2020-06-30: -41620000 USD · Inspect Operating Cash Flow · Source 2019-07-01 – 2020-06-30: 943000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2020-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -42563000 USD Concept: free-cash-flow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41620000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/agtc-20210630.xml#100902 Filing: 000119312521280686 Input fundies:CapitalExpenditure: 943000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/agtc-20210630.xml#102264 Filing: 000119312521280686 The citation records this snapshot. The page link may show a newer release later.
2021 2020-07-01 – 2021-06-30	−USD 57.83 million Exact value Exact value: -57829000 USD 2020-07-01 – 2021-06-30: -57829000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2021-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -57829000 USD Concept: fundies:NetIncome Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:NetIncome: -57829000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1424024 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	−USD 51.17 million Exact value Exact value: -51173000 USD 2020-07-01 – 2021-06-30: -51173000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2021-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -51173000 USD Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51173000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445983 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	USD 1.46 million Exact value Exact value: 1457000 USD 2020-07-01 – 2021-06-30: 1457000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2021-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 1457000 USD Concept: fundies:CapitalExpenditure Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1457000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449832 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	−USD 52.63 million Calculation and evidence -51173000 − 1457000 USD Exact free cash flow: -52630000 USD 2020-07-01 – 2021-06-30: -51173000 USD · Inspect Operating Cash Flow · Source 2020-07-01 – 2021-06-30: 1457000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2021-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -52630000 USD Concept: free-cash-flow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51173000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445983 Filing: 000119312522252231 Input fundies:CapitalExpenditure: 1457000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449832 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.
2022 2021-07-01 – 2022-06-30	−USD 68.94 million Exact value Exact value: -68943000 USD 2021-07-01 – 2022-06-30: -68943000 USD Inspect Net Income Open source Share or cite Citation for Net Income · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Net Income: -68943000 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ANetIncome&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:NetIncome: -68943000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1423574 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	−USD 65.75 million Exact value Exact value: -65748000 USD 2021-07-01 – 2022-06-30: -65748000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Operating Cash Flow: -65748000 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65748000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445499 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	USD 1.67 million Exact value Exact value: 1670000 USD 2021-07-01 – 2022-06-30: 1670000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Capital Expenditure: 1670000 USD Concept: fundies:CapitalExpenditure Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636/explain?concept=fundies%3ACapitalExpenditure&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1670000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449358 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.	−USD 67.42 million Calculation and evidence -65748000 − 1670000 USD Exact free cash flow: -67418000 USD 2021-07-01 – 2022-06-30: -65748000 USD · Inspect Operating Cash Flow · Source 2021-07-01 – 2022-06-30: 1670000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · APPLIED GENETIC TECHNOLOGIES CORP · 2022-06-30 APPLIED GENETIC TECHNOLOGIES CORP (edgar:1273636) Free cash flow: -67418000 USD Concept: free-cash-flow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T13:21:03Z Snapshot: 38529fc340317072601b28c30f3aa4444ac0f61b21628da00b44fccd0b6a7c36 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273636?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -65748000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1445499 Filing: 000119312522252231 Input fundies:CapitalExpenditure: 1670000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273636/000119312522252231/d374747d10k.htm#1449358 Filing: 000119312522252231 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

156 filings · 2,435 latest values · 2,435 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001273636, 1273636, AGTC, edgar:1273636

Also known as APPLIED GENETIC TECHNOLOGIES CORP, APPLIED GENETIC TECHNOLOGIES CORPORATION

APPLIED GENETIC TECHNOLOGIES CORP

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2021-07-01 – 2022-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation